GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.
Trial of live-attenuated vaccine VLA1553 was conducted in US, with high seroprotection rates observed in participants up to 180 days after vaccination. Study published in 'The Lancet'.
After decades of failed attempts due to the complexity of the virus, two vaccines co-developed by US scientists being tested in large pilot schemes by Vietnamese companies, WHO said.
The data was a 'worrying warning signal' of rising vaccine hesitancy amid misinformation, dwindling trust in governments and political polarisation, UNICEF said.
Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.
From 92% vaccination in 2019-20, the number of those given 1st dose dropped to 74% in 2021-22. This year, only 43% children in Mumbai had received 1st dose till October.
The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.
Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.
Lumpi-ProVac, a vaccine developed by 2 Indian Council of Agricultural Research institutes, was found effective in preventing lumpy skin disease in cattle & is ready for commercial launch.
As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.
COMMENTS